Giovanni A. Fava | Psychiatrist.com

Original Research

Assessing Demoralization and Depression in the Setting of Medical Disease

Original Research

The Clinical Domains of Psychosomatic Medicine

Review Article

The Clinical Process in Psychiatry: A Clinimetric Approach

Article

Cognitive-Behavioral Management of Drug-Resistant Major Depressive Disorder

Original Research

Cognitive-Behavioral Management of Patients With Bipolar Disorder Who Relapsed While on Lithium Prophylaxis

Article

Explanatory Therapy in Hypochondriasis

Original Research

Family Intervention Approach to Loss of Clinical Effect During Long-Term Antidepressant Treatment: A Pilot Study

Original Research

Can Long-Term Treatment With Antidepressant Drugs Worsen the Course of Depression?

Original Research

Psychological Characterization of Demoralization in the Setting of Heart Transplantation

Review Article

Role of Staging in Planning Psychotherapy Interventions for Depression

Staging differs from usual diagnostic practice in that it defines a person's current location on the continuum of the illness course. This critical review examines how staging supported by...

Original Research

Sequential Treatment of Mood and Anxiety Disorders

Original Research

The Spectrum of Anxiety Disorders in the Medically Ill

Commentary

Understanding and Managing Antidepressant Withdrawal Syndromes

In this commentary, the authors outline differing models of antidepressant withdrawal syndromes and discuss how the model a clinician uses can impact interpretation of phenomena as well as management...

Long-Term Benzodiazepine Treatment: Toward Evidence-Based Practice Guidelines

Commentary

Long-Term Benzodiazepine Treatment: Toward Evidence-Based Practice Guidelines

The evidence about long-term benzodiazepine use presents a confounding paradox. This commentary proposes a set of prescribing guidelines for clinicians.

Concerns About Long-Term Benzodiazepine Treatment: Reply to Sigler et al

Letter to the Editor

Concerns About Long-Term Benzodiazepine Treatment: Reply to Sigler et al

Edward Silberman and colleagues respond to a letter about their recent commentary calling for benzodiazepine prescribing guidelines.